1Cohen AT,Aqnelli G,Anderson FA,et al.VTE Impact Assessment Group in Europe(VITAE).Venous thromboembolism(VTE)in Europe.The number of VTE events and associated morbidity and mortality[].Thrombosis and Haemostasis.2007
2Young AM,Billingham LJ,Begum G,et al.Warfarin thromboprophylaxis in cancer patients with central venous cathers(WARP):an open-label randomized trial[].The Lancet.2009
3Geerts WH,Bergqvist D,Pineo GF, et al.Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.)[].Chest.2008
4PS Wells,C Owen,S Doucette,D Fergusson,H Tran.Does this patient have deep vein thrombosis?[].The Journal of The American Medical Association.2006
4Mulvey JM. Strategic financial risk management and operational re- search[J]. Eur J Oper Res, 1997, 97( 1 ) : 1-16.
5Blom JW,Doggen CJ,Osanto S,et al.Malignancies,prothrombotic mutations,and the risk of venous thrombosis[J].JAMA,2005,293(6):715-722.
6Chew HK,Wun T,Harvey D,et al.Incidence of venous thromboembolism and its effect on survival among patients with common cancers[J].Arch Intern Med,2006,166(4):458-464.
7Chew HK,Wun T,Harvey DJ,et al.Incidence of venous thromboembolism and the impact on survival in breast cancer patients[J].J Clin Oncol,2007,25 (1):70-76.
8Heit JA,Silverstein MD,Mohr DN,et al.Risk factors for deep vein thrombosis and pulmonary embolism:a population-based case-control study[J].Arch Intern Med,2000,160(6):809-815.
9Kakkar AK,Levine M,Pinedo HM,et al.Venous thrombosis in cancer patients:insights from the FRONTLINE survey[J].Oncologist,2003,8(4):381-388.
10Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review [ J ]. J Clin Pathol, 2004, 57(12) : 1254-1257.
